Skip to main content
Fig. 3 | Annals of Clinical Microbiology and Antimicrobials

Fig. 3

From: Comparison of the inoculum effect of in vitro antibacterial activity of Imipenem/relebactam and Ceftazidime/avibactam against ESBL-, KPC- and AmpC-producing Escherichia coli and Klebsiella pneumoniae

Fig. 3

IE of different treatment regimens at different inoculum sizes. ATCC-BAA 1705 (A), E. coli 56706 (B), K. pneumoniae 61089 (C) and K. pneumoniae 60700 (D). Data are expressed as the mean ± SD. 1–4 represent different dosing regimens: 1 = CZA 2.5 g q8h; 2 = CZA 1.25 g q8h; 3 = IMR 1.25 g q6h; and 4 = IMR 625 mg q6h

Back to article page

Annals of Clinical Microbiology and Antimicrobials

ISSN: 1476-0711

Contact us